Ergoteles’s Tenax Therapeutics TENX Stock Holding History

Ergoteles’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9	Closed	-$2K	–	1874
2022 Q3	$2K	Buy	+9	New	+$3.61K	﹤0.01%	1487

Other funds holding TENX

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's TENX Position: Q4 2022 in Review

Ergoteles sold out of Tenax Therapeutics (TENX) in Q4 2022, closing a stake of 9 shares — an estimated $2K sold.

Ergoteles first reported a position in TENX in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 14 funds tracked by Wall St. Rank hold TENX as of Q4 2022.

Ergoteles reported no remaining Tenax Therapeutics position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 9 Tenax Therapeutics shares in Q4 2022, an estimated $2K.
Ergoteles first reported a position in Tenax Therapeutics in Q3 2022 and held it in 1 quarter.
Ergoteles's Tenax Therapeutics position peaked at $2K in Q3 2022.
14 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.